Ads
related to: zytiga- Dosing & Administration
See Recommended NUBEQA® Dosage And
Learn About Drug Interactions Here.
- Clinical Information
Read About A Double-Blind, Placebo-
Controlled, Randomized Study.
- Contact A Bayer Rep
Stay Informed On Everything NUBEQA®
By Contacting A Bayer Rep Today.
- Second NUBEQA® Indication
NUBEQA® Treats 2 Indications
Get The Data You Need
- NUBEQA ARASENS Trial Data
View the Pivotal Data
See How NUBEQA® Can Help
- Patient Profiles
Explore Patient Profiles To See If
NUBEQA® May Be The Right Option.
- Dosing & Administration
akumin.com has been visited by 10K+ users in the past month
Search results
AstraZeneca's (AZN) 3 Cancer Drugs Get CHMP Nod for Expanded Use
Zacks via Yahoo Finance· 1 year agoAstraZeneca AZN and partner Merck MRK announced that the Committee for Medicinal Products for Human...
FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA
Zacks via Yahoo Finance· 1 year agoThe FDA extends the review period of AstraZeneca (AZN)/Merck's filing seeking label expansion for...
Johnson & Johnson (JNJ) Down 2.2% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 12 months agoIt has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have...
AstraZeneca's (AZN) Lynparza Gets Expanded Use Nod in Japan
Zacks via Yahoo Finance· 8 months agoAstraZeneca (AZN) gets approval for Lynparza with abiraterone and prednisolone combo in Japan to...
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
Zacks via Yahoo Finance· 2 weeks agoJohnson & Johnson’s JNJ first-quarter 2024 earnings came in at $2.71 per share, which beat the Zacks...
J&J (JNJ) Beats on Q2 Earnings & Sales, Lowers 2022 Guidance
Zacks via Yahoo Finance· 2 years agoJohnson & Johnson’s JNJ second-quarter 2022 earnings came in at $2.59 per share, which beat the...
Why Is Johnson & Johnson (JNJ) Down 0.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 months agoIt has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have...
J&J (JNJ) Beats Q3 Earnings & Sales Estimates Post Spin-Off
Zacks via Yahoo Finance· 7 months agoJohnson & Johnson’s JNJ third-quarter 2023 earnings came in at $2.66 per share, which beat the Zacks...
Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoJohnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript October 17, 2023 Operator: Good...
Ad
related to: zytiga